LSPN Connect: When IP and COVID-19 meet

The COVID-19 pandemic poses unprecedented challenges to the biomedical community as it strives to find the best solutions to fight COVID-19.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

LSPN Connect: MPP chief wants COVID-19 role

26 June 2020 The executive director of the Medicines Patent Pool says it should have a role in fighting COVID-19, but it’s up to stakeholders to agree what that will be.

Americas

BIO 2020: IP’s vital role in COVID-19 fight, potential ‘chaos’ of pooling

9 June 2020 Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.

Americas

LSPN Connect: CRISPR, IP headaches and ‘deplorable’ diversity

31 July 2020 The development of CRISPR technology is showing no signs of losing momentum, and Arbor Biotechnologies is one company that is taking full advantage of this. We spoke to Kelly Morgan, senior director, head of IP and legal at the company to find out more.

More on this story

Big Pharma

LSPN Connect: MPP chief wants COVID-19 role

26 June 2020 The executive director of the Medicines Patent Pool says it should have a role in fighting COVID-19, but it’s up to stakeholders to agree what that will be.

Americas

BIO 2020: IP’s vital role in COVID-19 fight, potential ‘chaos’ of pooling

9 June 2020 Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.

Americas

LSPN Connect: CRISPR, IP headaches and ‘deplorable’ diversity

More on this story

Big Pharma

LSPN Connect: MPP chief wants COVID-19 role

26 June 2020 The executive director of the Medicines Patent Pool says it should have a role in fighting COVID-19, but it’s up to stakeholders to agree what that will be.

Americas

BIO 2020: IP’s vital role in COVID-19 fight, potential ‘chaos’ of pooling

9 June 2020 Concerns that IP is hindering the development of tools to fight the COVID-19 are unfounded, and now is the time that we need IP the most, according to big pharma representatives.

Americas

LSPN Connect: CRISPR, IP headaches and ‘deplorable’ diversity